Background. Erythromycin is known to prolong ventricular repolarization and has been associated with the occurrence of torsades de pointes. In this study, we have investigated potential mechanisms in vivo and in vitro for induction of an acquired long QT syndrome by erythromycin.
Electrophysiological Mechanisms in a Canine
Model of Erythromycin-Associated Long QT Syndrome Michael Rubart, MD; Milton L. Pressler, MD; Harald P. Pride, BS; Douglas P. Zipes, MD Background. Erythromycin is known to prolong ventricular repolarization and has been associated with the occurrence of torsades de pointes. In this study, we have investigated potential mechanisms in vivo and in vitro for induction of an acquired long QT syndrome by erythromycin.
Methods and Results. Ventricular electrograms and endocardial monophasic action potentials were recorded in anesthetized open-chest dogs before and after administration of 40 to 120 mg/kg of erythromycin lactobionate. Conventional microelectrode techniques were used to record transmembrane action potentials in isolated dog Purkinje fibers and papillary muscles. Erythromycin at concentrations >20 mg/L prolonged action potential duration. At higher concentrations (100 to 200 mg/L), erythromycin induced phase 2 and phase 3 early afterdepolarizations (EADs) both in vivo and in vitro. The effects of erythromycin on repolarization were more marked in Purkinje fibers than in papillary muscle. Pretreatment of Purkinje fibers with erythromycin antagonized the effects of dofetilide, a selective delayed-rectifier potassium channel (IK) blocker. Pretreatment with prazosin or tetrodotoxin had no effect on erythromycin-induced changes in action potential duration.
Conclusions. These pharmacological studies suggest that erythromycin prolongs repolarization to a large extent by block of IK. In turn, prolongation of action potential duration resulting from erythromycin's actions on IK may promote the development of EADs. The induction of ventricular arrhythmias observed clinically after exposure to erythromycin may be related to the development of EADs. The rarity of occurrence of ventricular arhythmias suggests that other predisposing factors contribute to the acquired long QT syndrome associated with erythromycin. (Circulon. 1993; 88[part 11:1832 -1844 KEY WORDs * potassium * depolarizing * arrhythmia T he long QT syndrome is defined by prolonged ventricular repolarization and the occurrence of a multiform ventricular tachyarrhythmia called torsades de pointes. In its acquired form, the long QT syndrome has been associated with a variety of interventions and substrates.1-3 Administration of the macrolide antibiotic erythromycin has been reported to prolong ventricular repolarization and cause torsades de pointes4-8 by an unknown mechanism.
In canine Purkinje fibers in vitro, erythromycin has been shown to lengthen repolarization in a concentration-dependent fashion. Sporadic early afterdepolarizations (EADs) were seen but not recorded.7 Since increasing evidence3 implicates EADs and triggered activity as causes of torsades de pointes associated with long QT intervals, we investigated the effects of erythromycin on ventricular repolarization in vivo and in vitro and specifically tested whether it can provoke EADs. In addition, we explored the cellular mechanisms for the effects of erythromycin on the action potential in isolated canine Purkinje fibers and papillary muscles. The results demonstrate that erythromycin markedly prolongs repolarization and acts as a competitive inhibitor of the effects of dofetilide. Erythromycin also provoked EADs similar to those caused by class IA antiarrhythmic agents. Two abstracts of some of these findings have been reported previously.9'10 Methods
In Vivo Experiments
Surgical preparations. Details of the surgical techniques have been described previously. 11, 12 In brief, 10 mongrel dogs (weight, 12 to 25 kg) were anesthetized with thiopental (25 mg/kg IV) and with chloralose (5 to 10 mg kg`-h`IV) and ventilated by a constantvolume cycled respirator, and cannulas were placed in the left femoral artery and vein and right femoral vein. After median sternotomy, the ansae subclaviae were transected bilaterally, and both cervical vagi were cut to avoid autonomic reflex responses during experimentation. The sinus node was crushed and the right atrium paced at a constant cycle length of 600 milliseconds using 2- 
In Vitro Protocols
Erythromycin's effects on transmembrane action potentials were studied in 15 isolated dog Purkinje fibers and 3 papillary muscles that were stimulated continuously at 1 Hz. Measurements were obtained at 600, 800, 1000, 1200, 1500, 2000, 2500, and 3000 milliseconds cycle length during the control period and at 60, 90, and 120 minutes after erythromycin was added to the superfusate. Cycle lengths up to 30 seconds were also tested if permitted by intrinsic automaticity. In studies of Purkinje fibers, only experiments with impalements lasting throughout the experiments were accepted for analysis. In papillary muscles, impalements could not be maintained in the same cell throughout the study.
Consequently, the maximal rate (Vm,,) of phase 0 depolarization in papillary muscles was too variable for comparison between control and drug-treated states. Because of the cumulative effects of erythromycin, dose-response curves were done in Purkinje fibers by giving the drug in increasing doses (20, 50, 100 , and 200 mg/L). Action potentials were recorded before and at 60 minutes after exposure to erythromycin. Three papillary muscles were exposed to 100 and 200 mg/L erythromycin added cumulatively to the superfusate. To further define the mechanism for the action of erythromycin on transmembrane action potentials, the effects of different ion channel antagonists were studied in the absence and presence of erythromycin.
Role of late sodium channels in the effects of erythromycin. Activation of the "late sodium" or "window"' current18'9 might be one ionic mechanism by which erythromycin prolongs APD. given a cumulative dose of 120 mg/kg. Fig 1 shows 3 (data not shown). EAD amplitudes were more pronounced at longer diastolic intervals resulting from either increases in pacing cycle length (Fig 2) or compensatory pauses following premature ventricular complexes (Fig 3) . Re (Fig 9) . None of the effects of erythromycin on repolarization were antagonized by a1-adrenergic receptor blockade.
The increase in plateau potential and APD associated with erythromycin (see Fig 4) might result from an increase in inward calcium current (Ica). If so, developed tension might be expected to increase. Consequently, we measured changes in developed tension in three dog Purkinje fibers after exposure to erythromycin. Fig 10 shows The observations in vitro and in vivo probably represent identical electrophysiological phenomena. However, higher concentrations of erythromycin were required to induce EADs in Purkinje fibers in vitro, and the cycle lengths at which EADs occurred were significantly longer than in the intact heart. The difference might possibly be a result of circulating catecholamines released from the adrenal medulla. a-and .3-adrenergic receptor agonists have been shown to cause EADs or facilitate their induction both in vivo23 25 and in vitro. 24, 26 Circulating catecholamines may have shifted the cycle length-EAD relation to shorter cycle lengths under in vivo conditions, thereby increasing the propensity of the heart to develop EADs. A second possibility is that intravenous administration of erythromycin may have led to a more rapid initial tissue uptake and a higher intracellular concentration of the drug than when it was superfused in vitro. The observation that the maximum drug effect in vivo occurred 10 to 20 minutes after intravenous infusion of erythromycin, whereas its effects on transmembrane action potential characteristics did not reach steady state until 60 minutes of drug exposure, supports this mechanism. Finally, since low Baseline APD50 and APD90 were recorded 90 minutes after exposure to erythromycin. The two dose-response curves were from separate sets offour dog Purkinje fibers.
Origin of EADs and Production of Ventricular Arrhythmias In Vivo
EADs may result from spatial inhomogeneities of repolarization that cause electrotonic interactions between differently polarized regions or from oscillations of membrane currents.26-3' At first glance, our findings seem to support the former mechanism. Erythromycin was shown to increase Purkinje fiber APD much more than that of papillary muscle. Differences in repolarization between Purkinje fibers and contiguous muscle can simulate phase 3 EADs,1,32 and the observed EADs could have resulted from electrotonic interactions or reentrant activity within the tissue. However, the similarity of the phenomena produced by erythromycin to those induced by quinidine,2733-35 anthopleurin A (AP-A),15 cesium,l1ll236 clofilium, 37 In the present study, T wave changes on the surface ECG (Fig 3) and QTU alternans on the local bipolar electrogram (Fig 2) (IKi) , which contributes to repolarization during late phase 3. I' channels are a major determinant of the membrane potassium conductance at high negative potentials and thereby regulate the resting potential. We think it unlikely that erythromycin has substantial effects on IKi because there were no significant changes in Vm even when APD was lengthened by >100 milliseconds. Likewise, the minimal effect of erythromycin on developed tension argues against a substantive contribution of the sarcolemmal Ica and/or calcium-release channels of the sarcoplasmic reticulum to the changes in APD. Agents that raise the plateau of the action potential by enhancing ICa, eg, isoproterenol, also significantly shorten APD, an effect opposite to that observed with erythromycin. We have no explanation for the small transient increase in developed force occurring =10 minutes after exposure to erythromycin other than to state that it was not much larger than the error of the measurements. Furthermore, we cannot exclude an effect of erythromycin to block calciumactivated potassium channels. The potential role of erythromycin to stimulate sodium/calcium exchange or to inhibit the sodium/potassium pump current also remains within the realm of possibility.
We did consider whether erythromycin acts as an agonist for a1-adrenergic receptors in Purkinje cells. In rat ventricular myocytes, a1-adrenergic receptor stimulation decreases Ito, thereby prolonging APD.6768 We discount this possibility, however, because pretreatment with the a1-adrenergic receptor antagonist prazosin did not affect erythromycin-induced lengthening of APD (Fig 9) .
Clinical Implications
Five cases of torsades de pointes have been reported after administration of erythromycin, four after intravenous doses5-8 and one after oral intake of 1.5 g/d. 4 The erythromycin concentrations used in our in vitro and in vivo studies were high compared with plasma levels in patients. In healthy volunteers, peak serum erythromycin concentrations reach an average of 30 mg/L after intravenous administration of 900 mg erythromycin.69 This is above the threshold concentration for significant prolongation of APD in vitro (see Fig 4) . Thus 
